STAND. COM. REP. NO. 853-16
Honolulu, Hawaii
, 2016
RE: H.B. No. 254
H.D. 2
Honorable Joseph M. Souki
Speaker, House of Representatives
Twenty-Eighth State Legislature
Regular Session of 2016
State of Hawaii
Sir:
Your Committee on Consumer Protection & Commerce, to which was referred H.B. No. 254, H.D. 1, entitled:
"A BILL FOR AN ACT RELATING TO MEDICINES,"
begs leave to report as follows:
The purpose of this measure is to allow for the regulation of biosimilar medicines to ensure patient safety and access to medicines at lower prices.
Your Committee has amended this measure by:
(1) Specifying that within five business days following the dispensing of a biological product, the dispensing pharmacist or the pharmacist's designee shall communicate to the prescriber the specific product provided to the patient;
(2) Changing the effective date to July 1, 2112; and
(3) Making technical, nonsubstantive amendments for clarity, consistency, and style.
As affirmed by the record of votes of the members of your Committee on Consumer Protection & Commerce that is attached to this report, your Committee is in accord with the intent and purpose of H.B. No. 254, H.D. 1, as amended herein, and recommends that it pass Third Reading in the form attached hereto as H.B. No. 254, H.D. 2.
Respectfully submitted on behalf of the members of the Committee on Consumer Protection & Commerce,
|
|
____________________________ ANGUS L.K. McKELVEY, Chair |
|
|
|